Inovio to report fourth quarter and year-end 2023 financial results on march 6, 2024

Plymouth meeting, pa. , feb. 21, 2024 /prnewswire/ -- inovio (nasdaq:ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-associated diseases, cancer, and infectious diseases, today announced that fourth quarter and year-end 2023 financial results will be released after the market close on march 6, 2024.
INO Ratings Summary
INO Quant Ranking